The Epstein-Barr virus (EBV) latent membrane protein 2A (LMP2A) blocks B-cell receptor (BCR) signal transduction in EBV-immortalized B lymphocytes in vitro. The cytoplasmic amino-terminal domain of LMP2A contains an immunoreceptor tyrosine activation motif (ITAM). ITAMs consist of paired tyrosine and leucine residues and play a central role in signal transduction of the BCR and the T-cell receptor (TCR). To investigate the importance of the LMP2A ITAM, two EBV recombinants were constructed, each containing a tyrosine-to-phenylalanine point mutation at amino acid 74 or 85 within the ITAM of LMP2A. Tyrosine phosphorylation, calcium mobilization, and induction of BZLF1 expression were no longer blocked in the LMP2A ITAM mutant LCLs following BCR cross-linking. In addition, the Syk protein tyrosine kinase (PTK) was unable to bind LMP2A in unstimulated LCLs infected with either of the LMP2A ITAM mutants. Analysis of Syk phosphorylation before and after BCR cross-linking in the LMP2A mutant ITAM LCLs compared with wild-type EBV LCLs indicates a specific role of the LMP2A ITAM on the LMP2A-mediated negative effect on the Syk PTK. These data indicate the importance of the LMP2A ITAM motif in the LMP2A-mediated block on BCR signal transduction and position the role of the Syk PTK as being central to the function of LMP2A. ᭧ 1997 Academic Press 1 To whom correspondence and reprint requests should be adnoreceptor tyrosine-based activation motif (ITAM) ( Fig.   dressed at Department of Microbiology-Immunology, Northwestern 1A) (Reth, 1989; Cambier, 1995). Antigen-induced B-lym-
INTRODUCTION
den, 1989; Kaye et al., 1993; Tomkinson et al., 1993; Farrell, 1995) and EBNA1 is likely essential for lymphocyte Epstein-Barr virus (EBV) is a common human pathogrowth transformation, because it is required for EBV gen that is the causative agent of mononucleosis. EBV episome maintenance (Yates et al., 1985) . However, EBalso is associated with a variety of hemopoietic cancers NA3B, LMP2A, and LMP2B are dispensible for lymphosuch a African Burkitt's lymphoma, Hodgkin's disease, cyte transformation (Longnecker et al., 1992 (Longnecker et al., , 1993a , adult T-cell leukemia, and lymphoproliferative diseases 1993b; Tomkinson and Kieff, 1992) . Of the viral proteins occurring in individuals with congenital or acquired celluexpressed in latent infection, EBNA1, LMP1, and LMP2A lar immune deficiencies. Two epithelial diseases are also are the proteins consistently detected in NPC tumors associated with EBV infection: nasopharyngeal carcibiopsies, EBV-related malignancies, and lymphoprolifernoma (NPC), a malignancy endemic to southern China; ative diseases in AIDS patients [for review see Ambinder and oral hairy leukoplakia (OHL), an epithelial hyperplaand Mann (1994) ; Thorley-Lawson et al. (1996) ]. In addisia of the lingual squamous epithelium in AIDS patients tion, LMP2A and EBNA1 are the only messages of the [for review see Miller, (1990) ; Straus et al., (1993) ; Kieff, in vitro latently expressed proteins that have been de-(1996) ].
tected by PCR analysis from B lymphocytes purified from B lymphocytes infected with EBV and grown in vitro are individuals harboring EBV latent infections (Qu and immortalized and are termed lymphoblastoid cell lines Tierney et al., 1994; Chen et al., 1995) . Thus, (LCLs). These EBV-transformed LCLs contain EBV epi-EBNA1, LMP1, and LMP2A may have important roles in somes and nine virus-encoded proteins. Six are nuclear vivo for viral replication, persistence, and EBV-related proteins: EBNA1, EBNA2, EBNA3A, EBNA3B, EBNA3C, diseases in the human host. and EBNALP [for review see ], and three are The LMP2A protein, the subject of this study, localizes integral membrane proteins: LMP1 (Mann et al., 1985;  to numerous small patches in the plasma membrane of Wang et al., 1985) , LMP2A, and LMP2B (Frech et al.,  latently infected B lymphocytes Longnecker and Kieff, 1990; Rowe et al., 1990 Rowe et al., ). 1990 Longnecker et al., 1991) and most of the anti-phos-EBNA2, EBNA3A, EBNA3C, and LMP1 have been demonphotyrosine (APT) reactivity within these B cells is associstrated to be essential for EBV transformation of B lymated with these LMP2A patches . phocytes (Cohen et al., 1989; Hammerschmidt and Sug- Within the 119-amino-acid amino-terminal domain of LMP2A are 8 tyrosine residues, 2 of which form an immu-phosphorylated LMP2A might mimic activated receptor complexes, thereby competing for proteins with src homology 2 domains (SH2). SH2 domains are noncatalytic domains conserved among cytoplasmic signaling proteins which bind tyrosine phosphorylated proteins [for review, see Pawson and Gish (1992) ; Schaffhausen (1995) ].
Prior results with three deletion mutations within the amino-terminal domain of LMP2A indicated the potential importance of the LMP2A ITAM (Fruehling et al., 1996) , although these studies were hindered by potential artifacts that can be obtained by deletional mutagenesis. Thus, to further investigate the importance of the LMP2A ITAM in a site-specific approach, two separate point mutations were engineered into each of the tyrosine residues of the LMP2A ITAM. Each tyrosine was changed to a phenylalanine residue and these mutations were recombined into the EBV genome. LCLs infected with each LMP2A ITAM mutation, as well as wild-type controls, were tested for Syk association with LMP2A, 
MATERIALS AND METHODS
amino-acid cytoplasmic carboxyl domain. The eight tyrosine residues in the LMP2A amino-terminal domain are numbered and the binding Cell lines and cell culture of the two SH2 domains of the Syk PTK with LMP2A at tyrosine residues Y74 and Y85 is depicted. Tyrosine residues 74 and 85 of the LMP2A All cell lines were maintained in RPMI containing 10% ITAM were changed independently to a phenylalanine residue and inactivated fetal bovine serum, 1000 units/ml of penicillin, recombined into the EBV genome to generate LCLs containing each and 1000 mg/ml of streptomycin (Sigma). BJAB is an EBV-LMP2A ITAM mutation. negative B-lymphoma cell line (Menezes et al., 1975) . The HH514-16 subclone of the original EBV-infected P3HR1 (P3JHR1) Burkitt's lymphoma cell line (a gift of George sequential activation of the Syk PTK and the Src family PTKs and their interaction with phosphorylated ITAMs Miller) has only EBV genomes with a single type of DNA that is deleted for a segment encoding EBNA2 and the [for review see Bolen, (1993); Cambier et al. (1994) ; Weiss and Littman (1994); DeFranco (1995); Gold and Matsuu-last two exons of EBNALP (Heston et al., 1982) . WT1 and WT4 are EBV / LMP2A / lymphoblastoid cell lines (LCLs) chi (1995) ]. The Src family PTKs and the Syk PTK also associate with LMP2A Burk-and ES1 and ES4 are EBV / LMP2A 0 LCLs . Primary human mononuclear cells were obtained hardt et al., 1992; , and LMP2A induces the phosphorylation of Syk in vivo or in in vitro kinase from blood of healthy donors by centrifugation over a cushion of Ficoll-Paque (Pharmacia). For EBV-positive reactions Burkhardt et al., 1992; . Transfection studies of LMP2A cDNA donors, T lymphocytes were removed as previously described (Marchini et al., 1991) . mutant constructs into an EBV 0 B-lymphoma cell line have revealed that the amino-terminal 119-amino-acid domain of LMP2A is required for interaction with Syk and Construction of plasmids the Src family PTKs. Burkhardt et al., 1992) .
pSVNaeZ, used to induce lytic EBV replication and EcoRI-A, used to rescue the EBNA2 and EBNALP muta-EBV / LMP2A / LCLs are blocked in BCR-stimulated calcium mobilization, tyrosine phosphorylation, and lytic ac-tions contained in the P3HR1 cell line, have been described previously (Marchini et al., 1991 ; Swaminathan tivation compared with EBV / LMP2A 0 LCLs (Miller et al., 1993 . The 119-amino-acid cytoplasmic et al., 1991) . Tyrosine residues 74 and 85 of LMP2A were mutated to phenylalanine residues ( Fig. 1 ) using a PCR-amino-terminal domain of LMP2A is essential for this function of LMP2 (Burkhardt et al., 1992; based strategy. Genomic mutations were incorporated into pRH6 which contains a KpnI (B95-8, bp 161,097)-to-1994). LMP2A functions as a negative regulator of the Src family PTK, Lyn, and the Syk PTK .
EcoRI (B95-8, bp 1) fragment from B95-8 EBV DNA. All mutants were sequenced to confirm the presence of the Constitutively clustered membrane patches of tyrosine desired mutation and the absence of any mutations intro-tion. Ethidium bromide-stained PCR products were viewed after electrophoresis through 1.5% EEO agarose duced by PCR.
(Fisher) to identify the size of the amplified products.
Transfection
Identified LMP2A ITAM mutant LCLs and wild-type controls were further characterized for sIg expression by DNA used for transfections was banded twice on CsCl flow cytometry utilizing a fluorescein isothiocyanatedensity gradients. Recombinant cell lines were generlinked goat anti-human Ig (H / L) diluted 1:50 (Southern ated by transfecting 1 1 10 7 P3HR1 cells in 0.4 ml com-Biotech) as previously described (Miller et al., 1993) . plete RPMI with 15 mg pSVNaeZ, 7 mg EcoRI-A, and 25 mg recombinant LMP2A DNA. Cells were pulsed once Immunofluorescence with a Gene Pulser (Bio-Rad) at 200 V and 960-mF capacitance in a 0.4-cm electrode gap cuvette (Bio-Rad) and
Immunofluorescence of LCLs was performed as preimmediately diluted in 10 ml complete RPMI. The inducviously described . In brief, tion of lytic EBV replication in LCLs was performed simi-LCLs were fixed to glass slides with acetone at 020Њ for larly, except these cells were pulsed at 230 V with 25 mg 5 min, blocked with 20% normal goat serum for 10 min pSVNaeZ and diluted in complete RPMI containing 20 at room temperature, incubated with the anti-LMP2A rat ng of 12-O-tetradecanolylphorbol-13-acetate (TPA) per monoclonal antibody (Fruehling et al., 1996) , 14B7, dimilliliter.
luted 1:1000 for 1 hr at room temperature, incubated with a goat anti-rat-Cy3 secondary antibody diluted 1:1000 Mutation of the LMP2A ITAM (Jackson) for 30 min, washed in PBS, and viewed with a Zeiss fluorescence Axioscope. PCR-mediated mutagenesis was used to create EBV DNA fragments encoding LMP2A with point mutations in the LMP2A ITAM. Both of the recombinant LMP2A Immunoblotting constructs were verified by sequencing and then incor-LMP2A. LCLs (5 1 10 6 ) were washed twice in PBS, porated into virus through a strategy utilizing the transforlysed in 1% NP-40 lysis buffer [1% Nonidet-P40, 50 mM mation-incompetent, replication-competent EBV deletion Tris-HCl (pH 7.4), 150 mM NaCl, 2 mM EDTA, 10 mg mutant, P3HR1. Recombinant virus was generated by the (each) pepstatin and leupeptin per milliliter, 0.5 mM phecotransfection of the P3HR1 cell line with pSVNaeZ DNA, nylmethylsulfonyl fluoride, 1 mM sodium orthovanadate], to induce lytic viral replication; EcoRI-A DNA, to rescue and centrifuged at 4Њ to remove the insoluble materials. the EBNA2 and EBNALP deletions in the P3HR1 genome;
Lysates were heated at 70Њ for 5 min, separated by SDSand each of the recombinant LMP2A DNA fragments 8% PAGE, transferred to nitrocellulose, blocked with 4% (Longnecker et al., 1992) . The recombinant P3HR1 vimilk for 1 hr at room temperature, probed with the antiruses were used to infect primary blood mononuclear LMP2A 8C3 rat monoclonal antibody for 1 hr at room cells (PBMCs) or purified B lymphocytes in culture as temperature, incubated with horseradish peroxidasepreviously described (Fruehling et al., 1996) . Clones linked anti-rat secondary antibody for 30 min at room emerged 3 to 5 weeks after initial plating and were temperature (Amersham), washed with Tris-buffered sascreened by PCR for incorporation of the LMP2A ITAM line-Tween (TBST), and detected by enhanced chemilupoint mutations at 6 to 8 weeks. minescence (ECL) (Pierce). BZLF1. LCLs (4 1 10 6 cells) were either treated with PCR analysis and identification of LMP2A ITAM 100 mg/ml goat anti-human Ig F(ab) 2 (Jackson) or left mutant LCLs untreated for 48 hr at 37Њ. After incubation, cells were Genomic DNA from LCLs was prepared (Swaminathan washed in PBS and whole cell lysates were separated by et al., 1991) and amplified in a 25-ml volume for 40 cycles electrophoresis through SDS-8% PAGE. Proteins were as previously described (Longnecker et al., 1992) . transferred to nitrocellulose, blocked in 5% milk, incu-Primers 5LMP1 (CTAGGCGCACCTGGAGGTGG) and bated with BZ1 monoclonal antibody to the BZLF1 protein 3LMP1 (AGTCAGTCAGGCAAGCCTAT) were used to (Young et al., 1991) for 1 hr at room temperature, incuscreen LCLs containing the 81-bp smaller LMP1 gene bated with a secondary anti-mouse-HRP antibody (Amerpresent in the EBV genomic DNA fragment in which the sham), washed in TBST, and detected by ECL (Pierce). LMP2A mutations were incorporated. The LMP1 gene is adjacent to the LMP2A gene within the EBV genome.
Cellular activation and preparation of lysates After this initial screen, primers 5LMP2A (CTGCTGCAG-CTATGGGGTCC) and 374-LMP2A (TTGGGTTCCTAG-Tissue culture cells (cell number indicated in figure legends) were resuspended and equilibrated in serum-TGGTTGAA) were used to specifically amplify DNA from LCLs incorporating the LMP2AY74 ITAM point mutation, free RPMI for 15 min at 37Њ. Cells were stimulated with 25 mg/ml goat anti-human Ig (Southern Biotech) for the while primers 5LMP2A and 385-LMP2A (GTCGTGTTG-CAATCCCAAGA) were used to specifically amplify DNA indicated times and cells were immediately lysed in 1% NP-40 lysis buffer. The insoluble materials were removed from LCLs incorporating the LMP2AY85 ITAM point muta-by centrifugation at 4Њ and cleared supernatants were ( Fig. 1B) . Both of the recombinant LMP2A constructs were verified by sequencing (data not shown) and then processed for immunoprecipitations. incorporated into the EBV viral genome through a pre-Immunoprecipitations and immunoblotting viously described strategy (Longnecker et al., 1992) . The recombinant viruses generated were used to infect pri-Cleared lysates were incubated with the appropriate mary blood mononuclear cells (PBMCs) or purified B lymantisera for 1 hr at 4Њ, and immune complexes were phocytes in culture to generate LCLs as previously decaptured with either Protein A or G-Sepharose (Pharscribed (Fruehling et al., 1996) . The generated LCLs were macia) for 1 hr as indicated in the figure legends, folscreened by PCR to identify the presence of the LMP2A lowed by four washes with 1% NP-40 lysis buffer. Immu-ITAM mutations within the infecting EBV genome (data noprecipitated proteins were then resuspended in 21 not shown). Multiple cell lines were transformed by each SDS sample buffer, heated at 70Њ for 5 min, and sepaof the LMP2A ITAM recombinant viruses and these rated by electrophoresis through SDS-polyacrylamide EBV / LMP2AY74 and EBV / LMP2AY85 LCLs are characgels (percentages are indicated in the figure legends).
terized in this study. For immunoblotting, immune complex materials were electrophoresed and transferred to either nitrocellulose LMP2A protein expression in EBV / LMP2A ITAM or immobilon, as indicated in the figure legends. Memmutant LCLs branes were blocked for 1 hr at room temperature and then incubated in primary antibody, diluted in TBST, for 1 Expression of LMP2A in EBV / LMP2AY74 and hr at room temperature. Membranes were washed three EBV / LMP2AY85 LCLs was confirmed in immunoblots times in TBST, incubated with a horseradish-peroxidaseusing the LMP2A-specific antibody 8C3. Representalinked secondary antibody (Amersham) for 30 min at tive data are shown in Fig. 2 . LMP2A expression in room temperature, washed four times in TBST, and defour EBV / LMP2A / LCLs was clearly evident (Fig. 2 , tected by ECL (Pierce). Mouse monoclonal antibodies to lanes 3 -6), while no LMP2A was detected in the nega-Syk (4D10) and phosphotyrosine (PY20 and PY20-HRP) tive control EBV / LMP2A 0 LCL ES1 (Fig. 2, lane 2) or used in immunoprecipitations and immunoblots were the EBV 0 cell line BJAB (Fig. 2, lane 1) . LMP2A exprespurchased from Santa Cruz. sion in four representative EBV / LMP2AY74 LCLs (Fig.  2 , lanes 7 -10) and four representative EBV / LMP2AY85 Calcium mobilization LCLs (Fig. 2, lanes 11 -14) was similar to the LMP2A expression in EBV / LMP2A / LCLs. Immunofluores-Tissue culture cells (3 1 10 6 cells) were resuspended cence microscopy utilizing anti-LMP2A antibodies veriin loading buffer (145 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , fied that the LMP2A subcellular protein localization 1 mM CaCl 2 , 10 mM glucose, 10 mM HEPES, 1% BSA, within the EBV / LMP2AY74 and EBV / LMP2AY85 LCLs and 2.5 mM probenicid) and loaded with 2 mM calciumwas similar to LMP2A subcellular localization in binding dye, fluo-3-acetoxymethyl ester (fluo-3) for 30 min EBV / LMP2A / LCLs (data not shown) as previously deat room temperature (Molecular Probes). After loading, scribed (Fruehling et al., 1996) . the cells were washed twice and resuspended in loading buffer. The prepared cells were then measured for fluo-Syk PTK binding to the LMP2A ITAM rescence after BCR cross-linking with goat anti-human Ig F(ab) 2 antibody (Jackson) in a Perkin-Elmer LS-5B
In order to evaluate the specific interaction of Syk with luminescence spectrometer. Excitation and emission valthe LMP2A ITAM, unstimulated cellular lysates from ues for fluo-3 are 505 and 530 nm, respectively. Autofluor-EBV / LMP2AY74, EBV / LMP2AY85, and EBV / LMP2A / escence (or F min ) for each LCL was also determined by LCLs were tested in parallel immunoprecipitations with performing the above procedure without adding fluo-3 either LMP2A-specific antibodies or Syk-specific antidye. Baseline fluorescence was recorded for 1 min and bodies (Fig. 3) . LMP2A was immunoprecipitated from maximal fluorescence (F max ) was measured by addition EBV / LMP2AY74, EBV / LMP2AY85, and EBV / LMP2A / of digitonin (40 mM). Calcium concentration (nM) was LCLs and immunoblotted with a LMP2A-specific antibody calculated according to the formula [Ca 2/ ] Å 400 (F 0 to verify equal levels of immunoprecipitated LMP2A in F min )/(F max 0 F) (Merrit et al., 1990; Lee and Stern, 1994) . each of the LCLs (Fig. 3A) . LMP2A was not detected in an EBV / LMP2A 0 LCL included as a negative control (Fig.  RESULTS  3A) . To test for Syk interaction with LMP2A, Syk was immunoprecipitated from the same cellular lysates and Mutation of the LMP2A ITAM immunoblotted with either Syk-specific antibodies (Fig.  3B) , to confirm equal amounts of immunoprecipitated PCR-mediated mutagenesis was used to create EBV DNA fragments encoding LMP2A with point mutations in Syk, or LMP2A-specific antibodies, to investigate the interaction of Syk with LMP2A ( Fig. 3C) . Syk was readily the LMP2A ITAM. Each of the LMP2A tyrosine residues 74 (Y74) and 85 (Y85) within the amino-terminal domain immunoprecipitated from each of the LCLs, but the coimmunoprecipitation of LMP2A was detected only in of LMP2A was changed to a phenylalanine (F) residue LMP2AY74 LCLs (lanes 7 to 10) , and four EBV / LMP2AY85 LCLs (lanes 11 to 14) . No LMP2A expression was detected in the EBV 0 cell line BJAB (lane 1) or the EBV / LMP2A 0 LCL ES1 (lane 2). NP40 lysates of 1 1 10 7 LCLs were separated by SDS-8% PAGE, transferred to nitrocellulose, probed with the anti-LMP2A 8C3 antibody, incubated with horseradish peroxidase-linked secondary antibody, washed, and detected by ECL. LCL clone numbers are indicated above each lane and protein standards are indicated in kilodaltons.
the EBV / LMP2A / LCL and not in EBV / LMP2A 0 , missing either of the conserved tyrosine residues of the LMP2A ITAM, are unable to bind Syk. Hence, it appears EBV / LMP2AY74, or EBV / LMP2AY85 LCLs. These data demonstrate that unlike wild-type EBV / LMP2A / LCLs, that both tyrosine residues of the LMP2A ITAM are required for the interaction of LMP2A with Syk. the mutant EBV / LMP2AY74 and EBV / LMP2AY85 LCLs,
Mutation of the LMP2A ITAM restores BCR-activated tyrosine phosphorylation
To investigate the effect of the LMP2A ITAM mutations on the induction of PTK activity, one of the earliest known biochemical effects after BCR cross-linking, EBV / LMP2A / , EBV / LMP2AY74, and EBV / LMP2AY85 LCLs, matched for sIg expression by flow cytometry (data not shown), were analyzed for induction of tyrosine phosphorylation following BCR cross-linking. Representative data are shown in two immunoblots. The induction of tyrosine phosphorylation in two representative EBV / LMP2A / LCLs and two representative EBV / LMP2AY74 LCLs is shown in Fig. 4A and the induction of tyrosine phosphorylation for two representative EBV / LMP2A / LCLs and two representative EBV / LMP2AY85 LCLs is shown in Fig. 4B . In the four EBV / LMP2A / LCLs, a number of proteins are constitutively phosphorylated in unstimulated LCLs (Figs. 4A and 4B, lanes 1 and 4) and this pattern remains relatively unchanged after sIg cross-linking (Figs. 4A and 4B, lanes 2 and 3 and lanes 5 and 6). As described LCLs (A and B, lanes 1-6) , two EBV / LMP2AY74 LCLs (A, lanes 7-12), and two EBV / LMP2AY85 LCLs (B, lanes 7-12) are depicted before (0) and after (1 and 5 min) BCR cross-linking. LCLs (2 1 10 7 cells/ml) were either untreated (0) or treated with anti-sIg antibody for the indicated times and lysed in 1% NP-40 lysis buffer. Cleared lysates were immunoprecipitated with the PY20 APT antibody, captured with protein A-Sepharose beads, separated by SDS-8% PAGE, transferred to nitrocellulose, immunoblotted with the horseradish peroxidase-coupled PY20 antibody, and detected by ECL. LCL clone numbers are indicated above each group of lanes and protein standards are indicated in kilodaltons. stitutively phosphorylated and the phosphorylation ylation before and after BCR cross-linking were instate of LMP2A remained constistent at all time points vestigated in EBV / LMP2A / , EBV / LMP2AY74, and following BCR cross-linking, although the level of EBV / LMP2AY85 LCLs. The level of Syk within each LCL LMP2A phosphorylation within the ITAM mutant LCLs was determined using a Syk-specific antibody in immuwas reduced compared with EBV / LMP2A / LCLs. noprecipitation followed by a Syk immunoblot (Figs. 5A and 5C). Syk protein expression was similar in all cells, Syk is phosphorylated following BCR cross-linking in both wild-type and mutant. However, in studies using the the LMP2A ITAM mutant LCLs in contrast to same Syk immunoprecipitation followed by an antiphos-EBV / LMP2A / LCLs photyrosine (APT) immunoblot, induction of Syk phosphorylation was observed following BCR cross-linking in To investigate the effect of the LMP2A ITAM mutations on Syk phosphorylation, Syk protein levels and phosphor-the LMP2A ITAM mutant LCLs. Within four representative (data not shown), were loaded with the calcium-binding dye fluo-3 and monitored for fluorescence after BCR cross-linking. Previously described EBV / LMP2A / ( 
(A and C) The
Cell line type and name b No. c increase d level of immunoprecipitated Syk protein (A and C) is consistent before (0) and after (1 and 5 min) BCR cross-linking in four EBV / LMP2A / EBV / LMP2A / LCLs LCLs (A and C, lanes 1-6), two EBV / LMP2AY74 LCLs (A, lanes 7-9) WT1 7 8% (0-21%) and two EBV / LMP2AY85 LCLs (C, lanes 10-12). (B and D) Syk is WT4 11 13% (0-31%) constitutively phosphorylated prior to BCR cross-linking and there is no induction of phosphorylation of Syk following BCR cross-linking in WT.1.1 3 40% (0-65%) four EBV / LMP2A / LCLs (B and D, lanes 1-6) . Syk is not constitutively WT.1.7 3 26% (12-51%) phosphorylated in two EBV / LMP2AY74 LCLs (B, lanes 7-9) and two WT.8 4 23% (9-38%) EBV / LMP2AY85 LCLs (D, lanes 10-12) but Syk phosphorylation is WT.11 3 24% (15-30%) induced following BCR cross-linking within 1 min after BCR cross-WT.6 3 14% (10-17%) linking. LCLs (2 1 10 6 cells/ip) were treated with anti-sIg, lysates were WT.7 3 17% (15-19%) prepared, and anti-Syk immunoprecipitations followed by parallel Syk WT.23 3 18% (9-23%) or APT immunoblots were performed as indicated. Proteins were sepa-EBV / LMP2A 0 LCLs rated by duplicate SDS-8% PAGE, transferred to nitrocellulose, immu-ES1 5 244% (131-423%) noblotted with either the HRP-conjugated PY20 antibody or 4D10 anti-ES4 13 231% (131-345%) body followed by a HRP-conjugated protein A, and detected by ECL.
EBV / LMP2AY74 and EBV / LMP2AY85 LCL clone numbers are indicated above each group of lanes and pro-ITAM mutant LCLs tein standards are indicated in kilodaltons.
LMP2AY74 phorylated after BCR crosslinking (Fig. 5D, lanes 1-3 and LMP2A LCLs (Fig. 5B, lanes 7-9 and 10-12 ) and two LMP2AY85.F.3 2 76% (25-92%)
representative EBV / LMP2AY85 LMP2A LCLs (Fig. 5D , lanes 7-9 and 10-12) Syk was not phosphorylated bea LCLs (3 1 10 6 cells) were loaded with fluo-3-acetoxymethyl ester fore BCR cross-linking, but was rapidly phosphorylated in calcium binding dye or left untreated and measured for fluorescence (F) an inducible fashion following BCR cross-linking. These after BCR cross-linking in a luminescence spectrometer. The untreated cells revealed an autofluorescence value (F min ) for each LCL and the results indicate that each tyrosine residue of the LMP2A addition of digitonin to each cell sample gave a maximum fluorescence ITAM plays a critical role in the LMP2A-mediated inhibivalue (F max ) for each LCL. These values were then used to determine tion of Syk activation.
calcium mobilization by determining the calcium concentration, according to the formula [Ca 2/ ] Å 400(F 0 F min )/(F max 0 F) (Merrit et al., 1990; Lee and Stern, 1994) .
Calcium mobilization in EBV / LMP2A / and b WT1, WT4, ES1, and ES4 were previously described LCLs (Miller EBV / LMP2A ITAM mutant LCLs following et al., 1994) . All other LCLs were derived in this study.
BCR cross-linking
c Number of times calcium mobilization was determined for each LCL.
To assess the effect of the LMP2A ITAM mutations d The mean percentage increase of calcium was calculated for each on calcium mobilization, multiple EBV / LMP2A / , EBV / -LDL. Values in parentheses indicate the range of calcium values deter-LMP2AY74, and EBV / LMP2AY85 LCLs, derived in paralmined for each LCL that were used to calculate the mean percentage calcium increase. lel and matched for BCR expression by flow cytometry
DISCUSSION
In this study, each tyrosine of the LMP2A ITAM was demonstrated to be essential for the constitutive block in the BCR signal transduction cascade observed in EBVtransformed B lymphocytes. This motif plays an important role in the communication between the BCR and the Src family PTKs (Lyn, Blk, Fyn, and Lck) and the Syk PTK [for review see Bolen, (1993); Cambier et al. (1994); Weiss and Littman (1994); DeFranco (1995) ; Gold and Matsuu- 1 and 2, lanes 3 and 4, lanes  5 and 6, and lanes 7 and 8) . No induction of BZLF1 expression is region within EBV clinical isolates sequenced to date observed in EBV / LMP2A / LCLs (compare lanes 9 and 10 and lanes (Busson et al., 1995) . The LMP2A ITAM is also conserved 11 and 12). Whole-cell lysates of each in the LMP2A homologue in herpesvirus papio, a Bwere separated by SDS-8% PAGE, transferred to nitrocellulose, probed lymphotropic herpesvirus which naturally infects bawith BZ1 monoclonal antibody, incubated with a secondary anti-mouseboons (Franken et al., 1995) .
HRP antibody, and detected by ECL. LCL clone numbers are indicated above each pair of lanes and protein standards are indicated in kilodal-In this study, two EBV recombinant viruses were contons.
structed that encode a tyrosine-to-phenylalanine point mutation at LMP2A residue Y74 or Y85. LCLs were derived and analyzed for each mutant virus. Crossdemonstrate that both LMP2A ITAM tyrosine point mulinking the BCR on the ITAM mutant LCLs results in tant LCLs readily mobilize calcium following BCR crossa BCR signal transduction cascade characteristic of linking, unlike EBV / LMP2A / LCLs which demonstrate a normal B lymphocytes, EBV 0 B-lymphoma cell lines, or block in BCR cross-linking-induced calcium mobilization.
EBV / LMP2A 0 LCLs as determined by the induction of tyrosine phosphorylation, activation of the Syk PTK, Induction of BZLF1 expression in EBV / LMP2A ITAM release of intracellular calcium, and nuclear gene mutant LCLs following BCR cross-linking transcription as measured by activation of BZLF1 expression, whereas these events do not occur in In this study, the activation of lytic replication was in-EBV / LMP2A / LCLs (Burkhardt et al., 1992; Miller et vestigated Fruehling et al., 1996) . Mutating EBV / LMP2AY85 LCLs following BCR cross-linking by aneither of the LMP2A ITAM tyrosine residues also realyzing the expression of BZLF1, the immediate-early sults in loss of constitutive phosphorylation and bindtransactivator of EBV lytic replication. The BCR was ing of the Syk PTK to LMP2A. either untreated or cross-linked in representative Consistent with the data presented in this study is the EBV / LMP2AY74, EBV / LMP2AY85, or EBV / LMP2A / following model for the LMP2A-mediated block of signal LCLs for 48 hr and monitored for BCR-induced exprestransduction within latently infected B lymphocytes. In sion of BZLF1 by immunoblots with the BZ1 monoclonal this model, LMP2A constitutively aggregates in the antibody (Young et al., 1991; . BZLF1 plasma membrane of EBV-infected LCLs resembling expression is evident after BCR cross-linking in the two cross-linked BCRs. Like cross-linked BCRs, LMP2A rerepresentative EBV / LMP2AY74 LCLs (Fig. 6, lanes 2 and cruits cellular PTKs, resulting in the phosphorylation of 4) and the two representative EBV / LMP2AY85 LCLs (Fig. the tyrosines within the LMP2A cytoplasmic amino-termi-6, lanes 6 and 8). Whereas no BZLF1 expression is denal domain. In addition, LMP2A may also recruit SH3tected in any of the point mutants before BCR crosscontaining proteins or proteins with WW domains (Chen linking (Fig. 6, lanes 1, 3, 5, and 7) or in the EBV / LMP2A / and Sudol, 1995; Sudol et al., 1995) to its proline-rich LCL 1.1 either before or after BCR cross-linking ( Fig. 6, regions either before or after phosphorylation of the lanes 11 and 12). The EBV / LMP2A / LCL 6 had a small LMP2A tyrosines. In particular, the ITAM of LMP2A (Fig. amount of BZLF1 expression even without BCR cross-1) would be phosphorylated, resulting in the binding of linking (Fig. 6, lane 9) , but the level of BZLF1 did not the Syk PTK to LMP2A. Once bound, Syk would no longer increase following BCR cross-linking as observed in the be able to participate in normal BCR signal transduction. LMP2A ITAM mutants (Fig. 6, lanes 9 and 10) . These LMP2A might also desensitize or sequester other SH2data demonstrate that both the Y74 and the Y85 residues containing proteins through the interaction of their SH2 of the LMP2A ITAM play an important role in the LMP2Adomains with LMP2A phosphotyrosines. Recent studies mediated inhibition of nuclear gene transcription followhave determined the optimal phosphopeptide motif for ing BCR cross-linking and that the loss of either LMP2A binding a particular SH2 domain (Songyang et al., 1993 , ITAM tyrosine residue results in the induction of BZLF1 expression. 1994). LMP2A phosphotyrosine motifs similar to these identified motifs include potential binding sites for PI-3 vated resting B-cell phenotype in EBV-infected lymphocytes in normal individuals. kinase, PLCg2, Vav, Csk, and Lyn. Upon interaction with
We have shown that in in vitro systems, LMP2A dra-LMP2A, the functional activity of these proteins may be matically alters the phenotype of B lymphocytes by downaltered.
modulating signal transduction in LCLs expressing The importance of the Src family PTKs and the Syk LMP2A . Two roles for LMP2A PTK in BCR signal transduction and B-cell development in latent EBV infection may be hypothesized; both are has been demonstrated by homologous gene knock-outs related to the ability of LMP2A to block normal BCR signal of either PTK in both murine and chicken model systems transduction. The first role may be one in which LMP2A (Cheng et al., 1995; Hibbs et al., 1995; Nishizumi et al., alters the normal B-cell developmental program. This 1995; Turner et al., 1995) . The knock-out of Lyn from may occur in the bone marrow, which may serve as one chicken B cells, the only Src family PTK expressed in site of EBV latency in the human host (Gratama et al., chicken B cells, results in a severe decrease in BCR 1989 , 1992 . In mice knocked out for the Syk PTK, normal signaling, whereas the knock-out of Syk from chicken B-cell development is arrested prior to the B lymphocytes B cells results in total loss of competent BCR signal becoming BCR-positive in the bone marrow (Cheng et transduction (Takata et al., 1994) . These data position Turner et al., 1995) . If LMP2A has a similar Syk as the central mediator of BCR-mediated signal effect on the Syk PTK in immature B lymphocytes in the transduction. Interestingly, the absence of normal BCR bone marrow as it does in BCR-positive B lymphocytes, signal transduction in EBV / LMP2A / LCLs is very similar LMP2A may arrest normal B-cell development, allowing to the Syk PTK knock-out in chicken B cells.
EBV to occupy a privileged site in the bone marrow. The By mutating the ITAM of LMP2A and demonstrating second possible role of LMP2A in EBV latent infection the loss of LMP2A function, we have positioned the may be to block normal BCR signal transduction in order LMP2A ITAM and its effect on the Syk PTK as being to prevent activation of lytic EBV replication induced by central in the ability of LMP2A to block BCR signal trans-BCR signal transduction in peripheral B lymphocytes. The duction. Mutational analyses of ITAM sequences within importance of this function would be to prevent lytic replivarious lymphocyte receptors have indicated that both cation in latently infected B lymphocytes as they circulate tyrosines of the ITAM are essential for both BCR and in the peripheral blood, bone marrow, or lymphatic tis-TCR signal transduction [for review see Bolen (1993) ; sues where they might encounter antigens, superanti- Cambier et al. (1994) ; Weiss and Littman (1994); Degens, or other ligands that could engage B-cell receptors Franco (1995); Gold and Matsuuchi (1995) ]. Changing and activate EBV lytic replication. Transgenic animal either of the conserved tyrosines in the CD3e, TCR z model systems in which LMP2A is expressed in the Bchain, Ig-a, or Ig-b ITAM to a phenylalanine residue cell compartment may begin to address these issues. blocks normal signaling of chimeric proteins containing Further understanding of EBV latency in B lymphocytes these domains (Romeo et al., 1992; Irving et al., 1993;  might suggest novel treatments and therapeutics for Flaswinkel and Reth, 1994) . In addition, Zap-70 and Syk EBV-related diseases in humans. PTK binding to ITAM peptides requires phosphorylation of both ITAM tyrosines for maximum binding (Wange et ACKNOWLEDGMENTS al., 1993; Iwashima et al., 1994; Kimura et al., 1996) .
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